Clinical Trials Logo
  1. Home
  2. Kidney Transplantation
  3. NCT06147076
  4. Details
NCT06147076 Clinical Trial

Social Support Counseling Intervention for Kidney Transplant Candidates

Kidney Transplant Clinical Trial

— JtT  

Official title:
Journey to Transplant: Virtual Coaching for Potential Kidney Transplant Patients and Their Social Support Networks

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06147076
Other study ID # 1R01DK135730-01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 2024
Est. completion date September 2026

Study information
Verified date February 2024
Source Hennepin Healthcare Research Institute
Contact Allyson Hart, MD
Phone 612-873-6998
Email allyson.hart@hcmed.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Virtual Coaching for Potential Kidney Transplant Patients

Description:

Individuals who are eligible for kidney transplant will be recruited by phone or email and randomized into two groups, control and interventional counseling. The control group will be given a simple survey to fill and return while the interventional counseling will go through a group education and counseling session along with members of their social support networks. The interventional counseling will then complete a pre and post survey (same as control group). Survey answers will be recorded within REDCAP.

Recruitment information / eligibility
Status Recruiting
Enrollment 86
Est. completion date September 2026
Est. primary completion date May 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion - Determined by transplant center to be suitable for continuation in evaluation for listing (or a member of that person's social support network) - 18 Years of age or older - English-speaking - Willingness to participate with at least 2 social network members in the session and have calculator results shown to social network members (if a patient) - Able to provide informed consent Exclusion - Prisoners - Individuals with impaired ability to consent - Pregnant females. - Patients who choose to opt out of research. - Non-English speaking

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Social Support Network Counseling Intervention
Social support counseling intervention for kidney transplant candidates along with their social support networks.

Locations
Country Name City State
United States Hennepin Healthcare Minneapolis Minnesota

Sponsors (2)
Lead Sponsor Collaborator
Hennepin Healthcare Research Institute University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Correct Answers on Knowledge of Kidney Transplant Options Assessment Questionnaire one month
Secondary Decisional Conflict Scores Questionnaire one month
Secondary Social Support Scores Questionnaire one month
Secondary Knowledge Scores Questionnaire one month
Secondary Hearth Hope Index Questionnaire one month
See also
  Status Clinical Trial Phase
Completed NCT04087720 - Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Phase 4
Completed NCT03749356 - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients Phase 4
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT00498576 - Melatonin and Adiponectin in Hypertensive Kidney Transplant N/A
Completed NCT00642655 - Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation Phase 1/Phase 2
Completed NCT00374400 - The Paired Donation Consortium Paired Donation Program N/A
Completed NCT01710033 - A Study Of CP-690,550 In Stable Kidney Transplant Patients Phase 1
Completed NCT00205257 - Prediction of Acute Rejection in Renal Transplant Phase 1
Completed NCT02711826 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation Phase 1/Phase 2
Withdrawn NCT03978494 - Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. Phase 1
Completed NCT03837522 - Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies N/A
Not yet recruiting NCT06025240 - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed NCT05029310 - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients Phase 4
Completed NCT03644485 - Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Phase 4
Active, not recruiting NCT02409901 - Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients N/A
Completed NCT01047410 - ACtive Care After Transplantation, the ACT Study N/A
Completed NCT00940940 - Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Phase 4
Completed NCT00270712 - A Study of Factors That Affect Long-Term Kidney Transplant Function
Completed NCT00217126 - The Study of Long-term Deterioration of Kidney Transplants. Phase 4

External Links